GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exact Sciences Corp (NAS:EXAS) » Definitions » E10

Exact Sciences (Exact Sciences) E10 : $-2.57 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Exact Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Exact Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.600. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.57 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -15.60% per year. During the past 5 years, the average E10 Growth Rate was -22.20% per year. During the past 10 years, the average E10 Growth Rate was -17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Exact Sciences was 13.60% per year. The lowest was -30.10% per year. And the median was -13.10% per year.

As of today (2024-05-26), Exact Sciences's current stock price is $49.84. Exact Sciences's E10 for the quarter that ended in Mar. 2024 was $-2.57. Exact Sciences's Shiller PE Ratio of today is .


Exact Sciences E10 Historical Data

The historical data trend for Exact Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Sciences E10 Chart

Exact Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.09 -1.62 -2.02 -2.40 -2.50

Exact Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.46 -2.50 -2.50 -2.50 -2.57

Competitive Comparison of Exact Sciences's E10

For the Diagnostics & Research subindustry, Exact Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exact Sciences's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Exact Sciences's Shiller PE Ratio falls into.



Exact Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Exact Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.6/131.7762*131.7762
=-0.600

Current CPI (Mar. 2024) = 131.7762.

Exact Sciences Quarterly Data

per share eps CPI Adj_EPS
201406 -0.240 100.560 -0.315
201409 -0.390 100.428 -0.512
201412 -0.380 99.070 -0.505
201503 -0.400 99.621 -0.529
201506 -0.440 100.684 -0.576
201509 -0.450 100.392 -0.591
201512 -0.410 99.792 -0.541
201603 -0.490 100.470 -0.643
201606 -0.460 101.688 -0.596
201609 -0.360 101.861 -0.466
201612 -0.340 101.863 -0.440
201703 -0.320 102.862 -0.410
201706 -0.270 103.349 -0.344
201709 -0.230 104.136 -0.291
201712 -0.180 104.011 -0.228
201803 -0.330 105.290 -0.413
201806 -0.300 106.317 -0.372
201809 -0.370 106.507 -0.458
201812 -0.440 105.998 -0.547
201903 -0.660 107.251 -0.811
201906 -0.300 108.070 -0.366
201909 -0.310 108.329 -0.377
201912 0.540 108.420 0.656
202003 -0.910 108.902 -1.101
202006 -0.450 108.767 -0.545
202009 -1.350 109.815 -1.620
202012 -2.790 109.897 -3.345
202103 -0.180 111.754 -0.212
202106 -1.030 114.631 -1.184
202109 -0.970 115.734 -1.104
202112 -1.280 117.630 -1.434
202203 -1.040 121.301 -1.130
202206 -0.940 125.017 -0.991
202209 -0.840 125.227 -0.884
202212 -0.720 125.222 -0.758
202303 -0.420 127.348 -0.435
202306 -0.450 128.729 -0.461
202309 0.004 129.860 0.004
202312 -0.270 129.419 -0.275
202403 -0.600 131.776 -0.600

Add all the adjusted EPS together and divide 10 will get our e10.


Exact Sciences  (NAS:EXAS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Exact Sciences E10 Related Terms

Thank you for viewing the detailed overview of Exact Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Exact Sciences (Exact Sciences) Business Description

Traded in Other Exchanges
Address
5505 Endeavor Lane, Madison, WI, USA, 53719
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Executives
Brian Baranick officer: Gen. Mgr., Precision Oncology 441 CHARMANY DRIVE, MADISON WI 53719
Sarah Condella officer: SVP, Human Resources 441 CHARMANY DRIVE, MADISON WI 53719
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Everett Cunningham officer: Chief Commercial Officer C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Jeffrey Thomas Elliott officer: Chief Financial Officer 5505 ENDEAVOR LANE, MADISON WI 53719
James Edward Doyle director 5505 ENDEAVOR LANE, MADISON WI 53719
James Herriott officer: General Counsel 5505 ENDEAVOR LANE, MADISON WI 53719
Katherine S Zanotti director 431 E 9TH STREET, HINSDALE IL 60521
Jacob A Orville officer: General Manager, New Ventures 5505 ENDEAVOR LANE, MADISON WI 53719
Kevin T Conroy director, officer: Vice President 5505 ENDEAVOR LANE, MADISON WI 53719
D Scott Coward officer: SVP and General Counsel 441 CHARMANY DRIVE, MADISON WI 53719
Paul J Clancy director C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Graham Peter Lidgard officer: SVP, Chief Scientific Officer 5505 ENDEAVOR LANE, MADISON WI 53719
Michael S Wyzga director RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, CAMBRIDGE MA 02139
Torsten Hoof officer: General Manager, International 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063